BMO Capital analyst Alex Arfaei highlights that Pfizer (NYSE: PFE) management does not feel the urgency to do a large ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Rumors

Pfizer (PFE) PT Raised to $42 at UBSJanuary 31, 2018 9:37 AM Pfizer (PFE) PT Raised to $44 at Bernstein on 4Q Beat; 'Lower than Expected Tax Rate... Decent 2018 Guidance'January 31, 2018 8:58 AM Pfizer (PFE) PT Raised to $38 at Leerink PartnersJanuary 31, 2018 7:47 AM Pfizer (PFE) PT Raised to $42 at Deutsche Bank Following 4Q January 31, 2018 7:39 AM Pfizer (PFE) PT Raised to $41 at BarclaysJanuary 31, 2018 4:05 AM